Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-08
DOI
10.3389/fphar.2020.00457
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Cytotoxic Nitrogenated Azaphilones from the Deep-Sea-Derived Fungus Chaetomium globosum MP4-S01-7
- (2020) Weiyi Wang et al. JOURNAL OF NATURAL PRODUCTS
- Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
- (2020) Si-Min Qi et al. Frontiers in Cell and Developmental Biology
- MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53
- (2019) Wei Wang et al. CANCER LETTERS
- Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. Cell Communication and Signaling
- Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
- (2019) Dharambir Kashyap et al. SEMINARS IN CANCER BIOLOGY
- Natural product derived privileged scaffolds in drug discovery
- (2019) Emma K Davison et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Targeting MDM2 for novel molecular therapy: Beyond oncology
- (2019) Wei Wang et al. MEDICINAL RESEARCH REVIEWS
- Prevention of prostate cancer by natural product MDM2 inhibitor GS25: in vitro and in vivo activities and molecular mechanisms
- (2018) Wei Wang et al. CARCINOGENESIS
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy
- (2018) Jiang-Jiang Qin et al. Frontiers in Pharmacology
- Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy
- (2018) Wei Wang et al. CANCER RESEARCH
- Optimizing the outcomes of pancreatic cancer surgery
- (2018) Oliver Strobel et al. Nature Reviews Clinical Oncology
- Cytotoxic and Antibacterial Compounds from the Coral-Derived Fungus Aspergillus tritici SP2-8-1
- (2017) Weiyi Wang et al. Marine Drugs
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on nab-paclitaxel plus gemcitabine versus FOLFIRINOX
- (2017) Ali McBride et al. Expert Review of Clinical Pharmacology
- Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
- (2017) Jiang-Jiang Qin et al. Frontiers in Pharmacology
- Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
- (2017) Aurélien Lambert et al. Therapeutic Advances in Gastroenterology
- A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
- (2017) Wenbo Yao et al. EBioMedicine
- KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
- (2017) Jonas Cicenas et al. Cancers
- Cyclin D1, cancer progression, and opportunities in cancer treatment
- (2016) Shuo Qie et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials
- (2016) Catalina Mosquera et al. Cancer Genetics
- Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
- (2016) Jiang-Jiang Qin et al. Oncotarget
- Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
- (2016) Ritesh Kotecha et al. Oncotarget
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy
- (2015) Sukesh Voruganti et al. CANCER LETTERS
- Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
- (2015) Sukesh Voruganti et al. Oncotarget
- Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
- (2015) Jiang-Jiang Qin et al. Oncotarget
- Inulasesquiterpenoids: structural diversity, cytotoxicity and anti-tumor activity
- (2014) Guo-Wei Wang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of a New Class of MDM2 Inhibitor That Inhibits Growth of Orthotopic Pancreatic Tumors in Mice
- (2014) Wei Wang et al. GASTROENTEROLOGY
- Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF- B
- (2013) X. Li et al. CLINICAL CANCER RESEARCH
- Identification of the ZAK-MKK4-JNK-TGFβ Signaling Pathway as a Molecular Target for Novel Synthetic Iminoquinone Anticancer Compound BA-TPQ
- (2013) Deng Chen et al. CURRENT CANCER DRUG TARGETS
- miRNAs in Cancer Prevention and Treatment and as Molecular Targets for Natural Product Anticancer Agents
- (2013) Biyun Qian et al. CURRENT CANCER DRUG TARGETS
- Improvement of surgical results for pancreatic cancer
- (2013) Werner Hartwig et al. LANCET ONCOLOGY
- Advanced-stage pancreatic cancer: therapy options
- (2013) Jens Werner et al. Nature Reviews Clinical Oncology
- Bioactive eudesmane and germacrane derivatives from Inula wissmanniana Hand.-Mazz.
- (2013) Xiang-Rong Cheng et al. PHYTOCHEMISTRY
- Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
- (2012) Wei Wang et al. PLoS One
- Ginsenosides as anticancer agents: In vitro and in vivo activities, structure–activity relationships, and molecular mechanisms of action
- (2012) Subhasree Ashok Nag Frontiers in Pharmacology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started